Author Interviews, Global Health, Infections, Vaccine Studies / 24.06.2019
Antibody Points Way Toward Norovirus Vaccine
MedicalResearch.com Interview with:
Lisa Lindesmith, MS
Research specialist
Ralph S. Baric, PhD
Professor, Departments of Epidemiology, Microbiology and Immunology
Lineberger Comprehensive Cancer Center
Gillings School of Global Public Health
University of North Carolina
MedicalResearch.com: What is the background for this study? Would you briefly explain the types of outbreaks caused by Norovirus infections?
Response: Noroviruses cause about 20% of endemic and 50% of food-borne acute gastroenteritis, infecting all age groups, globally. While may different strains of norovirus cause outbreaks primarily in community settings, since the mid-1990’s the GII.4 strains of norovirus have caused waves of pandemic disease every 2-7 years. These pandemics are associated with emergence of a GII.4 strain that has changed key viral domains rendering the virus less susceptible to recognition by and protection from a person’s immune system. For a vaccine to be efficacious against pandemic GII.4 strains, it must be able to train the immune system to focus on the part of the GII.4 virus that does not change over time.
(more…)